Harm reduction and viral hepatitis C in European prisons: a cross-sectional survey of 25 countries

BACKGROUND: Current estimates suggest that 15% of all prisoners worldwide are chronically infected with the hepatitis C virus (HCV), and this number is even higher in regions with high rates of injecting drug use. Although harm reduction services such as opioid substitution therapy (OST) and needle...

Descripción completa

Detalles Bibliográficos
Autores principales: Bielen, Rob, Stumo, Samya R., Halford, Rachel, Werling, Klára, Reic, Tatjana, Stöver, Heino, Robaeys, Geert, Lazarus, Jeffrey V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5948815/
https://www.ncbi.nlm.nih.gov/pubmed/29751763
http://dx.doi.org/10.1186/s12954-018-0230-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5948815/
https://www.ncbi.nlm.nih.gov/pubmed/29751763
http://dx.doi.org/10.1186/s12954-018-0230-1

Ejemplares similares